Media ReleasesINOVIQ

View All INOVIQ News

INOVIQ - Appendix 4C and Quarterly Activities Report - September 2023

-- INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems
-- INOVIQ and ResearchDx sign a license and supply agreement for INOVIQ’s EXO-NET® pan-exosome capture product to provide EXO-NET services in the USA
-- Serum equivalence study confirms EXO-NET isolates extracellular vesicles (EVs) from both plasma and serum samples, enabling access to large biobanks for further research
-- SubB2M/CA15-3 study for breast cancer monitoring and SubB2M/CA125 analytical validation on-track for completion by end December 2023
-- INOVIQ CSO Professor Gregory Rice awarded the Joan Hunt Senior Award in Placentology
-- Post quarter, experienced director and investment banker, David Williams appointed Non-Executive Director and Chairman Elect effective 29 November 2023
-- Cash balance of $6.29m as at 30 September 2023

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?